Delivery Order SPE2DB20D2014-SPE2DB25FC78M
- Not listed
- The Defense Logistics Agency awarded a $2,852.93 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, issued on July 29, 2025. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used primarily for opioid use disorder treatment and alcohol dependence,...
- The Defense Logistics Agency awarded a delivery order valued at $2,154.63 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used primarily for opioid use...
- The Defense Logistics Agency awarded a $2,002.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with an ultimate completion date of June 30, 2025. This non-set-aside award was issued on June 27, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Vivitrol 380 mg vials with diluents. This is a firm fixed-price delivery order with a ceiling value of $6,007.02 and an ultimate completion date of August 14, 2025. The contract carries no set-aside designation, indicating it was competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,357.27 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of September 17, 2025. This is a firm fixed price contract with no set-aside designation, reflecting competitive procurement practices. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $3,003.51 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vivitrol is a medication used primarily in the treatment of alcohol and opioid use disorders, making this supply order critical...
- The Defense Logistics Agency awarded a $8,149.00 delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract, issued September 8, 2025, with a completion date of September 9, 2025, represents a firm fixed-price award with no set-aside designation. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $14,758.51 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,712.97 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 16, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Vivitrol is an extended-release naltrexone injection used in substance use disorder treatment, representing part of...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC78MDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use disorders, making this procurement part of the federal government's healthcare supply chain for military and veteran populations. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of medical product deliveries to support military healthcare systems globally. The company has demonstrated its capability to meet federal procurement requirements through competitive awards across a wide range of therapeutic domains, and this delivery order exemplifies the company's role in supplying specialized pharmaceutical products to support defense health initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/19/25 |